title: Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine I, University of Lübeck, Lübeck, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Fellermann
authors.forename: K R
authors.initials: KR
authors.lastname: Herrlinger
authors.forename: T
authors.initials: T
authors.lastname: Witthoeft
authors.forename: N
authors.initials: N
authors.lastname: Homann
authors.forename: D
authors.initials: D
authors.lastname: Ludwig
authors.forename: E F
authors.initials: EF
authors.lastname: Stange
mesh_terms: D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D011239:Prednisolone; D016559:Tacrolimus